CROI 2016 Program at a Glance
CONTINUING MEDICAL EDUCATION Accreditation Statement
and clinicians can receive a Certificate of Participation verifying their attendance, as required by the American Medical Association (AMA). Claiming CME Credits or a Certificate of Participation During the conference, daily evaluations will be e-mailed to all CROI participants to the e-mail account they used to register for the conference. OnThursday, February 25, 2016, all CROI participants will receive a final e-mail that will contain their registration confirmation number and a link to the overall CROI evaluation.To obtain CME credits or a Certificate of Participation for CROI, this final evaluation must be completed byThursday, March 31, 2016. Once the evaluation is submitted, participants will receive the link to claim and print their certificate. To determine the number of CME credits or hours that you can claim, calculate your time spent attending the relevant sessions, including plenary sessions, symposia, and workshops. For example, if you attended 2 plenary talks (8:30 AM to 9:30 AM), a themed discussion (1:45 PM to 2:45 PM), and a symposium (4:00 PM to 6:00 PM), you would have a total of 4 hours to apply toward CME credits for that day. At the end of CROI, please add the total hours you attended for your certificate.You may claim a maximum of 17 AMA PRA Category 1 Credits™ for this activity. A CME hour worksheet can be found here: http://www.croiconference. org/sites/default/files/uploads/croi2016_cme_worksheet.pdf Disclosure of Financial Relationships It is the policy of the IAS–USA to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty members (speakers, presenters, etc) participating in IAS– USA-sponsored activities are required to disclose to the program audience any financial interests within the past 12 months that could be perceived to influence, or give the appearance of potentially influencing, the written or oral presentation. (The ACCME defines a financial interest as an interest in any amount.)The information is intended to make the IAS–USA audience aware of speaker and contributor interests and commitments with commercial companies or other entities, enabling the audience members to form their own judgments about such associations. Each author or contributor is required to complete this financial disclosure declaration. In accordance with IAS–USA policy, the IAS– USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Disclosure information will be included with the Program and Abstracts eBook on the web. Drug and Product Disclaimer This activity may contain information about the investigational uses of drugs or products that are not approved by the US Food and Drug Administration. Please consult full prescribing information before using any medication or product mentioned in this activity.
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The IAS–USA designates this live activity for a maximum of 17 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Since 2006, the IAS–USA has held Accreditation with Commendation. As such, the IAS–USA belongs to an elite group of organizations in the United States that have been awarded this prestigious status, which, in the words of the ACCME, is“reserved for programs that are truly exceptional.” CME credits can be claimed for plenary lectures, symposia, opening session lectures, and special sessions. CME credits cannot be claimed for oral abstract sessions, themed discussion sessions, or poster sessions. Objectives After participating in CROI 2016, participants will be able to: • Describe new current basic science research on the pathogenesis of HIV and on advances toward a cure • List the most recent findings from clinical trials in the field of HIV and the implications of these data for state-of-the-art treatment strategies • Describe current epidemiologic data on the prevalence of HIV infection, transmission, treatment, and linkage to and retention in care in populations worldwide; the implications of these data for public-health program planning; and current advances in biobehavioral prevention Statement of Need Since HIV was identified, the scientific response to the global pandemic has been a coordinated effort among basic researchers, clinical investigators, health care providers, epidemiologists, and community leaders to move information and potential treatment options from research to clinical trials and out to affected communities as quickly as possible. CROI was founded in 1993 by researchers working in the field of HIV/AIDS and its complications, as a science- focused forum for exchanging current research findings among their international peers. CROI continues to focus on scientific exchange, providing an environment in which basic science researchers, translational researchers, clinical investigators, epidemiologists, and public health experts meet to present and discuss the latest research on different facets of HIV and its complications. CME Credit Information Physicians (MD, DO, and international equivalents) are eligible to receive CME credit for participation in CROI 2016. Other practitioners
Made with FlippingBook HTML5